Measurable residual disease-guided interventions in patients with acute myeloid leukaemia undergoing allogeneic haematopoietic cell transplantation: best practice recommendations from the European Society for Blood and Marrow Transplantation Practice Harmonisation and Guidelines Committee
Jaime Sanz, Gesine Bug, Fabio Ciceri, Charles Craddock, Richard Dillon, Jordi Esteve, Matteo Giovanni Della Porta, Michael Heuser, David C. de Leeuw, Arnon Nagler, Francesco Onida, Gail J. Roboz, Annalisa Ruggeri, Isabel Sánchez‐Ortega, Micha Srour, Ibrahim Yakoub‐Agha, Francesco Buccisano
Topics & Concepts
MedicineIntensive care medicineTransplantationPsychological interventionClinical PracticeImmunosuppressionMinimal residual diseaseHematopoietic cellOncologyMyeloidMyeloid leukemiaBest practiceDiseaseMyeloid leukaemiaHaematopoiesisHematopoietic stem cell transplantationHematologic NeoplasmsHematological disordersLeukemiaInternal medicineImmunologyGuidelineGood clinical practiceBone marrow transplantationBone transplantationAcute Myeloid Leukemia ResearchHematopoietic Stem Cell TransplantationMyeloproliferative Neoplasms: Diagnosis and Treatment